Topical Agent for Treatment of Red Skin

Phase 1

Completed

• Conditions: Rosacea; Bilaterally Symmetric Red Skin on Cheeks

• Registration Number: NCT00279890
• Lead Sponsor: Mayo Clinic

Brief Summary

SR-01 may reduce facial redness. it is a topically applied product. The agent will be applied to local skin areas of subjects with red facial skin to assess affect, and then applied to the whole face to assess efficacy and safety

Detailed Description

Not available

Study Timeline

• Study Start: 2005-07
• Study First Submitted: 2006-01-18
• Study First Submitted QC: 2006-01-18
• Study First Posted: 2006-01-20
• Primary Completion: 2007-01
• Study Completion: 2007-01
• Status Verified: 2011-05
• Last Update Submitted: 2011-05-20
• Last Update Posted: 2011-05-23

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Reduction of redness

Secondary Outcome Measures

Name	Time	Method
Safety and tolerability
Cosmetic acceptability

Trial Locations

Locations (1)

Mayo Clinic; 🇺🇸 Scottsdale, Arizona, United States